Predictable pharmacokinetics of ximelagatran, an oral direct thrombin inhibitor, in non-valvular atrial fibrillation patients receiving long-term treatment - Eriksson,U.G.; Bergqvist,D.; Kalebo,P.; Dahl,O.E.; Lindbratt,S.; Bylock,A. (Pathophysiol Haemost Thromb, 2002)